Evidence map›Paper›PMID 33017826›Full record

ReviewBlood purification2021

Peritoneal Dialysis Is an Option for Acute Kidney Injury Management in Patients with COVID-19.

José M Rodríguez-Chagolla, Enzo Vásquez Jiménez, Leticia Herrera Arellano, Alberto Villa Torres, Nayeli Acosta García, Dolores Aleman Quimbiulco, Sergio Armeaga Aguilar, Magdalena Madero

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Blood purification, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

José M Rodríguez-ChagollaNephrology Department, Centro Médico Issemym Toluca, Toluca de Lerdo, Mexico, jm.rodriguez.chagolla@gmail.com.
Enzo Vásquez JiménezNephrology Department, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico.
Leticia Herrera ArellanoNephrology Department, Centro Médico Issemym Toluca, Toluca de Lerdo, Mexico.
Alberto Villa TorresNephrology Department, Centro Médico Issemym Toluca, Toluca de Lerdo, Mexico.
Nayeli Acosta GarcíaNephrology Department, Centro Médico Issemym Toluca, Toluca de Lerdo, Mexico.
Dolores Aleman QuimbiulcoNephrology Department, Centro Médico Issemym Toluca, Toluca de Lerdo, Mexico.
Sergio Armeaga AguilarNephrology Department, Centro Médico Issemym Toluca, Toluca de Lerdo, Mexico.
Magdalena MaderoNephrology Department, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico.
Instituto Tecnológico de Toluca · MXInstituto Nacional de Cardiología · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In December 2019, cases of acute respiratory illness of unknown origin were reported in Wuhan, China. The disease is caused by "severe acute respiratory syndrome coronavirus 2". After identifying severe lung damage, injury to other organs, such as the kidney, has been identified. Peritoneal dialysis is a renal replacement therapy (RRT) and is at least as effective as other extracorporeal therapy options, with significant cost-effective advantages. However, this strategy is rarely used for the management of acute kidney injury in severe lung disease. In this review, we explore PD as an RRT strategy that may be a key instrument in countries and hospitals with limited access to all RRTs.

Indexed as

PandemicsPeritoneal DialysisSARS-CoV-2Acute Kidney InjuryAcute Lung InjuryAscitic FluidCatheterizationContainment of BiohazardsCOVID-19CytokinesDeveloping CountriesDisease ManagementHumansInfection ControlInflammationMedical Waste DisposalCytokinesMedical Waste DisposalAcute kidney injuryCOVID-19 diseasePeritoneal dialysis

Identifiers

PMID33017826
PMCPMC7573901
OpenAlexW3089569120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.